December 9, 2002, Vol 162, No. 22, Pages 2517-2647

Reviewers for 2002

Reviewers Who Completed a Review During 2002

James E. Dalen, MD, MPH

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2643-2647. doi:10.1001/archinte.162.22.2643

Editorial

The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism

James E. Dalen, MD, MPH

Abstract Full Text

Arch Intern Med. 2002;162(22):2521-2523. doi:10.1001/archinte.162.22.2521

Pain Management: A Call for Papers

Catherine D. DeAngelis, MD, MPH

Abstract Full Text

Arch Intern Med. 2002;162(22):2524. doi:10.1001/archinte.162.22.2524

Original Investigation

Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism: A Clinical Outcome–Based Meta-analysis

Giancarlo Agnelli, MD; Cecilia Becattini, MD; Timo Kirschstein, MD

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2537-2541. doi:10.1001/archinte.162.22.2537

Editorial
The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism
James E. Dalen, MD, MPH

Treatment for Hepatitis C Virus in Human Immunodeficiency Virus–Infected Patients: Clinical Benefits and Cost-effectiveness

Felicitas C. Kuehne, MSc; Ullrich Bethe, MD, MSc; Kenneth Freedberg, MD, MSc; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2545-2556. doi:10.1001/archinte.162.22.2545

Body Mass Index and the Risk of Stroke in Men

Tobias Kurth, MD, MSc; J. Michael Gaziano, MD, MPH; Klaus Berger, MD, MPH; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2557-2562. doi:10.1001/archinte.162.22.2557

Risk Factors for Coronary Heart Disease in African Americans: The Atherosclerosis Risk in Communities Study, 1987-1997

Daniel W. Jones, MD; Lloyd E. Chambless, PhD; Aaron R. Folsom, MD; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2565-2571. doi:10.1001/archinte.162.22.2565

Weight Change, Weight Fluctuation, and Mortality

S. Goya Wannamethee, PhD; A. Gerald Shaper, FRCP; Mary Walker, MA

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2575-2580. doi:10.1001/archinte.162.22.2575

Effect of Medicare Coverage on Use of Invasive Colorectal Cancer Screening Tests

Cynthia W. Ko, MD, ms; William Kreuter, MPA; Laura-Mae Baldwin, MD, MPH

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2581-2586. doi:10.1001/archinte.162.22.2581

Plasma Measurement of D-Dimer Levels for the Early Diagnosis of Ischemic Stroke Subtypes

Walter Ageno, MD; Sergio Finazzi, MD; Luigi Steidl, MD; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2589-2593. doi:10.1001/archinte.162.22.2589

Diabetes, Plasma Insulin, and Cardiovascular Disease: Subgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)

Hanna Bloomfield Rubins, MD, MPH; Sander J. Robins, MD; Dorothea Collins, ScD; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2597-2604. doi:10.1001/archinte.162.22.2597

Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?

Jeff Nagge, BScPhm, BSc; Mark Crowther, MD, MSc; Jack Hirsh, MD, FCCP

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2605-2609. doi:10.1001/archinte.162.22.2605

Depressive Symptoms, Unemployment, and Loss of Income: The CARDIA Study

Mary A. Whooley, MD; Catarina I. Kiefe, MD, PhD; Margaret A. Chesney, PhD; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2614-2620. doi:10.1001/archinte.162.22.2614

Incidence of Adipose Tissue Alterations in First-Line Antiretroviral Therapy: The LipoICoNa Study

Massimo Galli, MD; Alessandro Cozzi-Lepri, PhD; Aana Lisa Ridolfo, MD; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2621-2628. doi:10.1001/archinte.162.22.2621

Review

Corticosteroid Therapy for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review

J. M. Singh, MD; V. A. Palda, MD, MSc; M. B. Stanbrook, MD; et al.

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2527-2536. doi:10.1001/archinte.162.22.2527

In This Issue of Archives of Internal Medicine

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):2517. doi:10.1001/archinte.162.22.2517

Editor's Correspondence

Medication Assistance Programs: Eligibility and Enrollment

Greg Speicher, PharMD

Abstract Full Text

Arch Intern Med. 2002;162(22):2629. doi:

Medication Assistance Programs: Eligibility and Enrollment—Reply

Marie Chisholm, PharMD, FCCP; Joseph T. DiPiro, PharMD, FCCP

Abstract Full Text

Arch Intern Med. 2002;162(22):2629. doi:

Combined Vitamin E and Vitamin C Supplement Use and Risk of Cardiovascular Disease Mortality

Joel A. Simon, MD, MPH

Abstract Full Text

Arch Intern Med. 2002;162(22):2630. doi:

Combined Vitamin E and Vitamin C Supplement Use and Risk of Cardiovascular Disease Mortality—Reply

J. Michael Gaziano, MD, MPH; Jorg Muntwyler, MD, MPH

Abstract Full Text

Arch Intern Med. 2002;162(22):2630. doi:

Reflections on Malpractice

Daniel Reinharth, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2630. doi:

"Defensive Medicine" and Malpractice Suits

Jonas Brachfeld, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2631. doi:

Practicing Patient-Centered Medicine Each Day Won't Keep the Lawyers Away

Elliot M. Wortzel, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2631. doi:

Ten Points for a National Health Plan

J. Gary Grant, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2631. doi:

Ten Points for a National Health Plan—Reply

David U. Himmelstein, MD; Steffie Woolhandler, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2632. doi:

Nicotine Lozenge Trial: A "Real-World" Perspective

Raoul A. Walsh, BA, DiP Ed, PhD

Abstract Full Text

Arch Intern Med. 2002;162(22):2632. doi:

Nicotine Lozenge Trial: A "Real-World" Perspective—Reply

Saul Shiffman, PhD

Abstract Full Text

Arch Intern Med. 2002;162(22):2633. doi:

The Impact of Hospitalists on Congestive Heart Failure

Martin Terplan, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2633. doi:

The Impact of Hospitalists on Congestive Heart Failure—Reply

Peter K. Lindenauer, MD, MSc; Rona Chehabeddine, MPH; Penelope Pekow, PhD; et al.

Abstract Full Text

Arch Intern Med. 2002;162(22):2634. doi:

Periodontitis in Estrogen-Deficient Women

Harry W. Daniell, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2634. doi:

Periodontitis in Estrogen-Deficient Women—Reply

Roberto Civitelli, MD; Charles Hildebolt, PhD, DDS

Abstract Full Text

Arch Intern Med. 2002;162(22):2635. doi:

Intraventricular Block and Atrioventricular Conduction

David H. Spodick, MD, DSc

Abstract Full Text

Arch Intern Med. 2002;162(22):2635. doi:

Using Trade Names: Sometimes It Helps

Christopher Anton, MA, MEng; Anthony Richard Cox, BPharm, MRPharmS; Robin Esmond Ferner, MSc, MD, FRCP

Abstract Full Text

Arch Intern Med. 2002;162(22):2636. doi:

Trade Name, INNs, and Medication Errors

Michael R. Cohen, RPh, MS, ScD

Abstract Full Text

Arch Intern Med. 2002;162(22):2636. doi:

Trade Name, INNs, and Medication Errors—Reply

Matthias Schwab, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2636. doi:

Lack of Cardioprotective Effect of Naproxen

Debabrata Mukherjee, MD; Steven E. Nissen, MD; Eric J. Topol, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2637. doi:

Aspirin Use May Change Cost-effectiveness of COX-2 Inhibitors

A. Simon Pickard, PhD; Glen T. Schumock, PharmD, MBA

Abstract Full Text

Arch Intern Med. 2002;162(22):2637. doi:

Aspirin Use May Change Cost-effectiveness of COX-2 Inhibitors—Reply

James E. Dalen, MD, MPH

Abstract Full Text

Arch Intern Med. 2002;162(22):2638. doi:

Cyclooxygenase-2 Inhibitors and Myocardial Infarction

Mark R. Goldstein, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2639. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain

Peter Jüni, MD; Paul Dieppe, MD; Matthias Egger, MD

Abstract Full Text

Arch Intern Med. 2002;162(22):2639. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Daniel Solomon, MD, MPH; Jerry Avorn, MD; Robert J. Glynn, PhD, ScD

Abstract Full Text

Arch Intern Med. 2002;162(22):2640. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Elham Rahme, PhD; Louise Pilote, MD, mph, phd; Jacques LeLorier, MD, phd, FRCPC

Abstract Full Text

Arch Intern Med. 2002;162(22):2641. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Douglas J. Watson, PhD; Thomas Rhodes, MS; Bing Cai, MS; et al.

Abstract Full Text

Arch Intern Med. 2002;162(22):2642. doi:

CME Announcement

CME Hiatus: July Through December 2002

Abstract Full Text

free access

Arch Intern Med. 2002;162(22):e2536. doi:10.1001/archinte.163.9.1075

February 2023 - January 1908

Decade

Year

Issue

December 9, 2002, Vol 162, No. 22, Pages 2517-2647